Home›Stock Screener›Star Source Multi Trade

Star Source Multi Trade Share Price Today | Stock Price & Star Source Multi Trade Share Screener

STARSOURCE Pharmaceuticals & Biotechnology
Live Share Price BSE
₹92.00
▲ 4.00 (4.55%)
2026-11-18 00:00:00

As of November 18, 2026, the live Star Source Multi Trade share price (BSE: STARSOURCE) is ₹92.00, up 4.55% from the previous close, with shares trading between ₹83.75 and ₹92.00 in today's trading session, and a 52-week range of ₹71.01–₹145.75. Track STARSOURCE market cap trends to gauge the company's total market size. Use the Star Source Multi Trade stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Star Source Multi Trade opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Star Source Multi Trade Market Cap ₹15.05 Cr.
STARSOURCE P/E Ratio (TTM) -
Star Source Multi Trade P/B Ratio 12.16
EPS (TTM) ₹-9.66
Dividend Yield -
Debt to Equity -
STARSOURCE 52 Week High ₹145.75
Star Source Multi Trade 52 Week Low ₹71.01
Operating Margin -
Profit Margin -
STARSOURCE Revenue (TTM) -
EBITDA -
Net Income -
Total Assets ₹4.00
Total Equity ₹4.00

Star Source Multi Trade Share Price Chart

Track the current stock price of Star Source Multi Trade with an interactive chart. Analyse STARSOURCE share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Star Source Multi Trade stock quote in one place.

The quote of ₹92.00 sits between the 52-week low of ₹71.01 and the 52-week high of ₹145.75, and the latest session moved 4.55% from the previous close.

Star Source Multi Trade Company Profile - Fundamental Screener

Screen Star Source Multi Trade company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for STARSOURCE shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals & Biotechnology industry, and it trades under ISIN INE320M01019.

Company Details

Classification

Sector Healthcare
Industry Pharmaceuticals & Biotechnology
Sub-Sector Pharmaceuticals & Biotechnology
Segment E

Identifiers and Leadership

ISIN INE320M01019

Star Source Multi Trade Balance Sheet Screener

Screen STARSOURCE balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2016, total assets were ₹4.

Latest statistics put total assets at ₹4 and shareholder funds at ₹4.

Item 2016

Assets

Total Assets 4
Current Assets 0
Fixed Assets 0

Liabilities

Total Liabilities 0
Current Liabilities 0
Non-Current Liabilities 0

Shareholders' Equity

Total Equity 4
Share Capital 2
Reserves & Surplus 2

Star Source Multi Trade Income Statement Screener - Profit & Revenue Analysis

Screen Star Source Multi Trade income statement and profit fundamentals. Analyze STARSOURCE quarterly results. Star Source Multi Trade reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For None-None, revenue was ₹0 and net profit was ₹0.

In that period expenses were ₹0, interest cost ₹0 and tax ₹0. The next period listed, 2016-March, shows revenue of ₹-1 and net profit of ₹-1.

Item None-None 2016-March

Revenue and Expenses

Revenue 0 -1
Expenses 0 0

Operating Costs and Margins

EBITDA 0 -1
Operating Profit % 0.00% 0.00%
Depreciation 0 0
Interest 0 0

Profit and Earnings

Profit Before Tax 0 -1
Tax 0 0
Net Profit 0 -1
EPS 0.00 -9.66

Star Source Multi Trade Cash Flow Screener - Liquidity Fundamentals

Screen STARSOURCE cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2016-March, operating activities used ₹2.

Over the same period, investing activities provided ₹2 and financing activities provided ₹0.

Item 2016-March

Cash from Operations and Investing

Operating Activities -2
Investing Activities 2

Financing and Net Cash

Financing Activities 0
Net Cash Flow 0

Star Source Multi Trade Shareholding Pattern Screener

See Star Source Multi Trade shareholding pattern with promoter, FII, and DII holdings. Check Star Source Multi Trade promoter holding and ownership changes for STARSOURCE on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 27.89%, foreign institutions 0.00%, domestic institutions 0.37% and the public 65.82%, spread across 6,292 shareholders.

The shareholder count was 6,292 in 2026-Mar, compared with 6,264 in 2026-Jun.

Item 2026-Mar 2026-Jun 2026-Sept 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar

Promoter Holding

Promoter Holding 27.89% 27.89% 27.89% 27.89% 27.89% 27.89% 27.89% 27.89%

Institutional Investors

FII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
DII Holding 0.37% 0.37% 0.37% 0.37% 0.37% 0.37% 0.37% 0.37%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 65.82% 65.72% 65.86% 65.29% 65.77% 65.66% 65.69% 65.61%
Other Holding 5.93% 6.03% 5.89% 6.46% 5.98% 6.09% 6.06% 6.14%
Shareholder Count 6,292 6,264 6,218 6,510 6,422 6,409 6,360 6,262

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Star Source Multi Trade. Star Source Multi Trade dividend yield can be compared with peers and other stocks in the market.

No dividends declared by Star Source Multi Trade.

Star Source Multi Trade Stock Index Membership - Nifty & Sensex

See which indices include Star Source Multi Trade stock. Check STARSOURCE index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Complete Index List

Star Source Multi Trade is not part of any tracked indices.
Only major market indices are tracked in our system.

Star Source Multi Trade Market Events Screener - Corporate Actions

Get Star Source Multi Trade corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Star Source Multi Trade stock events that may affect STARSOURCE share price, along with derivatives, futures and options activity and sector gainers.

13 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated November 5, 2026, with a record date of November 5, 2026.

It is followed by Annual General Meeting dated September 28, 2026 and Quarterly Result Announcement dated August 14, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-11-05 2026-11-05 Quarterly Result Announcement NA 8.79%
2026-09-28 2026-09-28 Annual General Meeting NA -12.38%
2026-08-14 2026-08-14 Quarterly Result Announcement NA 10.70%
2026-05-29 2026-05-29 Quarterly Result Announcement NA -0.22%
2026-02-12 2026-02-12 Quarterly Result Announcement NA -3.50%
2025-11-13 2025-11-13 Quarterly Result Announcement NA 7.76%
2025-09-24 2025-09-24 Change Of Name NA 0.00%
2025-09-24 2025-09-24 Annual General Meeting NA -13.88%
2025-08-12 2025-08-12 Quarterly Result Announcement NA 11.63%
2025-05-29 2025-05-29 Quarterly Result Announcement NA 18.64%
2025-01-27 2025-01-27 Quarterly Result Announcement NA -12.17%
2024-10-28 2024-10-28 Quarterly Result Announcement NA -7.07%
2024-09-23 2024-09-23 Annual General Meeting NA -5.56%

Star Source Multi Trade Competitors Screener - Peer Stocks Comparison

Screen STARSOURCE competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 451,075 41.20 61,674 12.69% 11,565 63.60
Divis Laboratories 303,749 90.40 11,067 13.95% 2,568 78.53
Torrent Pharmaceuticals 177,632 85.50 13,886 20.34% 2,138 47.27
Laurus Labs 130,972 97.10 6,868 22.01% 890 69.60
Zydus Life Science 118,693 28.00 27,658 17.64% 5,026 52.34
Dr Reddys Laboratories 115,186 42.00 35,059 3.90% 4,158 70.24
Cipla 112,438 39.90 29,045 2.24% 3,870 54.92
Mankind Pharma 109,044 48.10 14,636 14.85% 1,938 65.43
Aurobindo Pharma 104,903 26.00 34,145 5.56% 3,503 66.06
Lupin 90,557 17.60 29,039 26.75% 5,356 44.92

Star Source Multi Trade Company Announcements - News & Reports Screener

Screen STARSOURCE latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated November 10, 2026.

The next most recent announcements are dated November 9, 2026 and November 9, 2026.

Date Update Actions
2026-11-10 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-11-09 Unaudited Financial Result For Period Ended On Sep 30 2026 -
2026-11-09 Board Meeting Outcome for Outcome Of Board Meeting (Q2 Finanial Results For The Period Ended On September 30 2026) -
2026-10-31 Board Meeting Intimation for Q2 Results (BM Postponed From 02/11/2026 To 05/11/2026) -
2026-10-26 Board Meeting Intimation for Board Meeting On November 02 2026 -
2026-10-09 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-09-29 Shareholder Meeting / Postal Ballot-Scrutinizers Report -
2026-09-28 Shareholder Meeting / Postal Ballot-Outcome of AGM -
2026-09-26 Closure of Trading Window -
2026-09-03 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-09-02 AGM On September 28 2026 -
2026-09-02 Reg. 34 (1) Annual Report. -
2026-09-01 Annual Book Closure For AGM For FY 2025-26 -
2026-09-01 Board Meeting Outcome for Outcome Of Board Meeting -
2026-08-31 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-08-27 Board Meeting Intimation for Board Meeting Intimation -
2026-08-16 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-08-14 Unaudited Financial Result For The Quarter Ended On June 30 2026 -
2026-08-14 Board Meeting Outcome for Board Meeting Held On August 14 2026. -
2026-08-11 Board Meeting Intimation for Considering Unaudited Financial Results For The Quarter Ended On June 30 2026. -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹92.00, within a 52-week range of ₹71.01 to ₹145.75. The P/B ratio is 12.16. Market capitalisation stands at ₹15.05 Cr. The company operates in the Healthcare sector, in the Pharmaceuticals & Biotechnology industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the BSE. Key statistics were last updated on November 19, 2026. This page covers 1 balance sheet periods, 2 income statement periods, 1 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.